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CLINICAL RESEARCH PAPERS
Computed tomography assessment of abdominal
aortic aneurysm morphology after endograft exclusion
Rodney A. White, MD,a Carlos E. Donayre, MD,a Irwin Walot, MD,b Jonathan Woody, MD,a Namil Kim,
MD,a and George E. Kopchok, BS,a Torrance, Calif
Objectives: Assessment of the long-term function of endografts to exclude abdominal aortic aneurysm (AAA) includes determi-
nation of aneurysm dimensions and morphologic changes that occur after implantation. This study reports the dimensional
analysis of patients treated with AneuRx bifurcated endoprostheses with postintervention, 1-year (n = 51), 2-year (n = 28), and
3-year (n = 10) postimplantation contrast computed tomography data.
Methods: Maximal diameter (D) and cross-sectional area (CSA) of the AAA were measured from axial computed tomography
images. Total volume, AAA thrombus volume (AAA volume minus the volume of the device and luminal blood flow), diame-
ter of the aorta at the level of the renal arteries and within the device, distance from the renal arteries to the device, length of
the device limbs, and the angle of the proximal neck were also determined at the same follow-up intervals after deployment
with computed tomography angiograms reconstructed in an interactive environment.
Results: Fifty-one of 98 consecutively treated patients with the AneuRx bifurcated prosthesis (29 “stiff” and 22 “flexible” body
devices) had complete data from the postprocedure and follow-up computed tomography studies available for analysis. Max D,
CSA, total volume of the AAA, and AAA thrombus volume decreased sequentially from year to year compared with the postim-
plantation values. D and CSA decreased or were unchanged in all except four patients, two who had unrestricted enlargement
of the aneurysm with eventual rupture and one who had surgical conversion for continued expansion despite four diagnostic
angiograms and attempted embolizations. Total volume of the AAA increased in 11 of 51 patients at 1 year, eight of whom
had endoleaks at some interval during the follow-up. Thrombus volume increased more than 5% in four of these patients,
including the two with eventual rupture and the one conversion. Patients with endoleaks who had spontaneous thrombosis or
were successfully treated either remained at the same volume or had decreased volume on subsequent examinations. D at the
renal arteries increased an average of 0.9 mm during the first year, with a concomitant increase of 2.8 mm within the proximal
end of the device related to the self-expanding nature of the Nitinol suprastructure. Subsequent enlargement of the proximal
neck continued at a slow rate in some cases but never exceeded the diameter of the endoluminal device. The distance from the
renal arteries to the device increased by an average of 3 mm over the first year, with the greatest increases occurring in patients
with a “stiff” body device and those with rapid regression (>10% total volume) in 1 year. As regression of the AAA occurred,
the angle of the proximal neck varied from -5° to +25° from the original alignment. Limb length varied from -8 mm to +10
mm, with no consistent pattern for the change, that is, ipsilateral or contralateral limb.
Conclusion: Significant variation in the quantitation of aneurysm size occurs depending on the technique of computed tomog-
raphy assessment used. In most patients diameter assessment is adequate, although volumetric analysis appears to be very help-
ful in certain patients who do not show aneurysm regression, or in whom the diameter increases or where endoleaks persist.
Three-dimensional reconstruction and volumetric analysis are also useful to assess the mechanism by which the endovascular
device accommodates to morphology changes and to determine criteria for reintervention. (J Vasc Surg 2001;33:S1-10.)
Exclusion of aneurysms with endovascular prosthe-
ses is developing rapidly and relies on expedient, precise
imaging protocols to appropriately select patients for
procedures and to assess performance after deploy-
ment. Development of an algorithm to cost-effectively
monitor aneurysms after exclusion is a priority for cur-
rent development and relies on determining the natural
history of the abdominal aortic aneurysm (AAA) at var-
ious intervals after treatment. There are now many
patients who are several years following exclusion of
AAAs using endovascular prostheses. Careful analyses
of sequential images that display the morphologic
changes that occur over time are now available to study
this important phenomenon.
Most patients appropriately chosen for treatment with
endografts demonstrate slow progressive decrease in
aneurysm size and require only periodic imaging to ensure
proper positioning of the device and maintenance of
decompression of the aneurysm sac.1-22 In as many as 5%
to 15% of patients, endoleaks at follow-up intervals of 1 to
3 years present a challenging diagnostic problem and in a
small percentage require a secondary intervention to
retard progressive aneurysm enlargement and prevent rup-
ture.2-4 Aneurysm enlargement has also been observed in
patients without endoleak, suggesting the pressurization
of the sac can be sustained by transmission through
thrombus even where there is no evidence of flow on
imaging studies.5,6
In most patients in whom the aneurysm slowly
decreases in size after successful exclusion, surveillance is
required to ensure that realignment of the device related
to aneurysm morphology changes does not adversely
affect function.1-4,7,14,19-21 Three-dimensional spiral (heli-
cal) computed tomography (CT) scans have been found to
be particularly useful in addressing the phenomenon and
were used in this study to assess the effect of morphologic
changes on aneurysm exclusion and device function.1,7-19
This study is based on a unique set of data in which all
patients reported had helical/spiral CT images that pro-
vided quantitative assessment of morphology at each inter-
val. The study reports the dimensional analysis of patients
treated with the AneuRx bifurcated endoprosthesis who
had postimplantation helical contrast CT images that were
available at each designated follow-up interval and that
were acquired with the same CT protocol.
METHODS
All patients in this report were part of the phase I, II,
and III Food and Drug Administration-approved U.S.
trial of the AneuRx bifurcated prosthesis. Patients were
entered into a protocol approved by the Institutional
Review Board at our institution and signed consents were
obtained for the investigational devices and the surveillance
protocols including the helical/spiral CT images used to
generate the data in this study. Fifty-one of 98 consecutively
treated patients had complete data from the postprocedure
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Fig 1. Interactive CT angiogram (left) demonstrating appearances of aorta neck when images are acquired perpendicular to patient, as
in conventional axial CT scan (top right), and when image is acquired at right angles to centerline of aortic lumen (bottom right).
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and the 1- (n = 51), 2- (n = 28), and 3- (n = 10) year fol-
low-up CT studies available for analysis. Twenty-nine
patients had the original “stiff” body prosthesis implanted,
and 22 had the new “flexible” segmented body device.
Special attempts were made to acquire CT data sets that
corresponded to the study protocol for patients with
endoleaks and special problems, for example, ruptures, so
that these phenomena could be carefully investigated in
detail. Other patients who had been monitored but did not
have complete CT data corresponding to this criterion were
not included in this analysis to enhance the accuracy and
comparability of the data.
Maximal diameter (D) and cross-sectional area (CSA)
of the AAA were measured from axial CT images. CSA
was determined with the formula π r2, with the radii being
one half of the major and minor diameters of the
aneurysm at the area of largest diameter on the printed x-
ray images of axial CTs, with the images acquired perpen-
dicular to the long axis of the patient. CT parameters for
the acquisitions were helical/spiral mode with slice recon-
struction at 2 or 3 mm, collimation 5, and pitch 1:1.5.
The original data set from the spiral CT scans with the
acquisition parameters described previously were used to
determine total volume, AAA thrombus volume (AAA
volume minus the volume of the device and luminal blood
flow), diameter of the aorta at the level of the renal arter-
ies and within the device, distance from the renal arteries
to the device measured from the slice immediately below
the lowest renal artery, length of the device limbs, and the
angle of the proximal neck with CT angiograms recon-
structed in an interactive environment (Medical Media
Systems, West Lebanon, NH). With the interactive soft-
ware environment, diameters of the aortic segments were
measured in a plane perpendicular to the centerline of the
aortic lumen rather than in slices acquired perpendicular
to the body of the patient, as is the case with conventional
axial CT images (Fig 1). Angles along the length of the
device were determined from the interactive images by
measuring the angle of a line displayed through the center
of the aortic lumen, defined as the included angle among
three points: the lumen at the renal artery take-off, the
proximal end of graft, and the graft flow divider (Fig 2).
RESULTS
Fifty-one of 98 consecutively treated patients with the
AneuRx bifurcated device had complete data from the
postprocedure and the 1- (n = 51), 2- (n = 28), and 3- (n
= 10) year follow-up CT studies available for analysis.
Other patients who had been monitored but did not have
CT at all intervals or did not have CT data acquired at the
designated intervals were not included to enhance the
accuracy and comparability of the data. Max D, CSA, total
volume of the AAA, and AAA thrombus volume decreased
sequentially from year to year compared with the postim-
plantation values in most patients. Table I displays the
mean and range of values at each interval.
D and CSA decreased or were unchanged in all except
for four patients, two of whom had unrestricted enlarge-
ment of the aneurysm with eventual rupture and one who
had surgical conversion for continued expansion despite
four diagnostic angiograms and attempted embolization
procedures. Total volume increased in 11 of 51 patients at
1 year, eight of whom had endoleaks at some interval dur-
ing the follow-up (Table II). Thrombus volume increased
more than 5% in four of these patients, including the two
with eventual rupture and the one conversion20,21 (Fig 3).
Patients with endoleaks that either had thrombosis or that
were successfully treated remained at the same volume or
had decreased volume on subsequent examinations (Fig
4). D at the renal arteries increased an average of 0.9 mm
during the first year, with a concomitant increase of 2.8
mm within the proximal end of the device related to the
self-expanding nature of the Nitinol suprastructure.
Subsequent enlargement of the proximal neck continued
at a slow rate in some cases but never exceeded the diam-
eter of the endoluminal device. Table III displays the com-
parison of the maximal diameter of aneurysm measured
Fig 2. CT angiogram showing technique for measuring angles
along device with centerline technique.
Table I.
Max D (mm) % CSA
Pre 1 year 2 years 3 years 1 year 2 years 3 years Post
53.6 -4.4 -7.5 -11.7 -18 -24 -42 179 
(46 to 80) (+2 to 16) (+8 to -20) (-5 to -20) (+5 to -72) (+13 to -74) (-23 to -71 ) (24 -302)
(n = 51) (n = 51) (n = 26) (n = 10) (n = 47) (n = 28) (n = 10) (n = 51)
Two-year values do not include two patients who had increases in maximum diameter percent CSA, total volume of the AAA, and thrombus 
leading to eventual rupture.
Max D, Maximum diameter.
from axial CT images acquired perpendicular to the
patient and diameters measured perpendicular to the cen-
terline on interactive reconstructions in patients with
endoleaks or volume increases to analyze the effect of the
two methods of determining D in this group of patients
with special issues. The patient data in Table III are for the
same 15 patients displayed in Table II.
The distance from the renal arteries to the device
increased by an average of 3 mm during the first year, with
the greatest increases in length between the renal arteries
and the proximal device occurring in patients with a “stiff
body” device. There were no instances of proximal move-
ment of the device. In the 29 patients with stiff devices, all
had 1-year CT images, with 15 having no change in renal-
device distance and 12 having movement of 3 to 14 mm.
One patient had a proximal suprarenal cuff added during
this interval to treat a proximal leak that developed with
no movement of the device. At 2 years 28 patients with
stiff body devices had CT studies, with seven of the 12
devices having increased distance at 1 year, continuing to
move an additional 2 to 6 mm from the 1-year location.
One device, which had not moved during the first year,
had an increase in distance of 3 mm. In two patients with
migrations of 6 and 16 mm by 2 years associated with
angulation of the proximal neck as the aneurysms
decreased by 7% and 22% volume during the same inter-
val, proximal suprarenal cuffs were added, which stopped
the migration and angulation through the third-year eval-
uation. At 3 years 10 patients with stiff body devices had
follow-up studies, and two patients showed an additional
increase in renal-device distance of 3 mm and 13 mm. The
patient with the 13-mm increase in the third year had a
concomitant decrease in the aneurysm volume of 15%
between years 2 and 3, whereas no movement of the
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Table II. Patients with endoleaks and/or volume increase during study
No. ∆ Max D (mm) % CSA Total volume
1 -10 mm year 1; remains -44% years 1 and 2; -28% years 1, 2, and 3
-10 mm through 3 years -49% year 3
2 No change year 1; No change year 1; +19% year 1; +103%, year 2
+20 mm year 2 +56% year 2
3 -5 mm year 1 -21% year 1 +10% year 1
4 No change through 2 years -5% year 1;-0% year 2 +7% years 1 and 2
5 -2 mm years 1 and 2 -8% years 1 and 2 -1% years 1 and 2
6 -10 mm years 1 and 2 -24% year 1; -32% year 2 -19% year 1; -27% year 2
7 -3 mm years 1 and 2 -9% years 1 and 2 +7% years 1 and 2
8 +3 mm year 1; +5 mm year 2 +4% year 1; +11% year 2 +15% year 1; +44% year 2
9 0 mm year 1; +3 mm year 2 0% year 1; +13% year 2 +5% year 1; +14% year 2
10 0 mm year 1 0% year 1 0% year 1
11 0 mm year 1 0% year 1 0% year 1
12 0 mm year 1 0% year 1 +3% year 1
13 +6 mm year 1 +15% year 1 +22% year 1
14 -5 mm year 1 -15% year 1 +3% year 1
15 -2 mm year 1 -5% year 1 +5% year 1
Change in maximum diameter and CSA measured from axial computed tomography images acquired perpendicular to long axis of patient.
∆ Max D, Change in maximum diameter.
IMA, inferior mesenteric artery.
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Total volume of AAA segment (cc) AAA thrombus volume - [device + blood volume] (cc)
1 year 2 years 3 years Post 1 year 2 years 3 years
161 153 145 106 98 85 78
(85-324) (82-324) (82-224) (76-259) (28-234) (25-227) (24-133)
(n = 49) (n = 28) (n = 10) (n = 48) (n = 48) (n = 28) (n = 10)
device was seen up to 2 years, during which total volume
had decreased by 6%. Of the 10 patients with 3-year fol-
low-ups, three had received proximal suprarenal cuffs and
showed no further migration (two to correct neck angula-
tion with regression of the aneurysm and one to seal a
proximal leak). Three patients had no migration, that is,
less than a 2-mm renal-device length change with total
volume changes of 0%, -2%, and 24%, and four patients
had devices with renal-device migrations of 5 to 15 mm
during the 3 years with concomitant total volume
decreases of 21%, 28%, 32%, and 36% and thrombus vol-
ume decreases of 54%, 40%, 59%, and 69%, respectively.
Twenty-two patients in the study had flexible body
devices implanted after this device was introduced to
replace the stiff body prosthesis. At year 1 there was no
change in the renal to device distance from the postproce-
dure position in 16 patients, whereas six devices had a
change in position of 5 to 12 mm: three in patients with
type II endoleaks and total volume increases of 2% to 4%
and three with total volume decreases of 10%, 19%, and
29% (thrombus volume -19%, -43%, and -58%, respec-
tively). At 2 years only eight patients with flexible devices
had follow-up studies with no changes in renal artery to
device position noted.
Throughout the study the angle of the proximal neck
varied from -5° to +25° from the original alignment. Fig
5 demonstrates the associated device changes that
occurred over a 3-year period in a patient with an angled
proximal neck. Limb length varied from -8 mm to +10
mm with no consistent pattern from the change, that is,
ipsilateral or contralateral limb. No adverse events were
correlated with the changes in limb length except for the
possible role of a 5-mm contralateral limb increase in a
patient after AAA expansion, the tilting of a modular limb
AAA thrombus volume Endoleak Resolution
+40% years 1, 2, and 3 Lumbar leak apparent 6 Observation yearly Max D and volumes
months and persists
+15% year 1;+106% year 2 No leak year 1; modular Aneurysm rupture
junction leak on CT 2 years
+9% year 1 Lumbar -IMA leak Patient denies intervention or further follow-up; 
alive at 2 years in nursing home
+2% years 1 and 2 Proximal leak Proximal cuff added at 6 months; leak resolved
-3% years 1 and 2 Proximal leak after procedure, Observation
resolved by 30 days
-31% year 1; -44% year 2 Distal limb leak Distal cuff at 6 months; leak resolved
+1% years 1 and 2 None identified Investigation for endotension recommended
+20% year 1; +43% year 2 Lumbar - accessory renal leak Patient denied intervention at 12 months, 
aneurysm rupture at 24 months
+1% years 1 and 2 None Increase surveillance; CT in 3 months, angiogram pending
0% year 1 Lumbar - IMA leak Sealed by 1 month
+4% year 1 Lumbar leak Spontaneous thrombosis at 15 months
0% year 1 Lumbar leak Embolization of IMA, aneurysm thrombosed with coils 
plus thrombin
+46% year 1 Lumbar- IMA IMA coil embolization x2 - surgical conversion for 
continued volume increase
0% year 1 Lumbar - IMA leak CT at 3-month intervals
-4% year 1 Lumbar - IMA leak IMA embolization planned
dural morbidity and mortality have been documented with
endovascular procedures compared with conventional
repairs, the new syndromes associated with endoluminal
devices including endoleaks and continued pressurization
of the aneurysm sac requiring secondary interventions pre-
sent new challenges to ongoing improvement.5 In addi-
tion, a low yet significant rate of late rupture after
endoluminal repair also presents a limitation and significant
challenge for current investigations. The cause of compli-
cations, particularly the incidence of rupture, has been
partly elucidated by careful studies evaluating individual
case scenarios.21 An important component of these analy-
ses is a review of the adaptation of endoluminal devices to
the change in aortic morphology that occurs after endo-
graft deployment. In most patients, after endoluminal
repair of AAAs is performed, there is a slow and progres-
sive decrease in the aneurysm diameter that leads to a
realignment of the aneurysm within the abdominal cavity
and a change in the angulation and length of adjacent ves-
sels and fixation sites. This realignment of the aneurysm
morphology combined with the potential for continued
endoleak enlargement in patients with progressive aneurys-
mal disease leads to further challenges for device improve-
ments and long-term surveillance protocols.
The increasing emphasis on imaging of patients with
endografts has also led to similar studies in patients with
concurrent surgical repair of aneurysms. The renewed
interest in aneurysm morphology and the application of
newer imaging methods, particularly CT scans and mag-
netic resonance three-dimensional imaging, have demon-
JOURNAL OF VASCULAR SURGERY
S6 White et al February 2001
Fig 3. Interactive images displaying increase in volume of 4 cc to 12 cc in this enlarging lumbar-inferior mesenteric artery endoleak as
aneurysm volume increased from 164 to 180 cc over 3-month interval. Illustrations are from patient 13, Table II.
that had short overlap, and the development of a modular
junctional leak that led to eventual AAA rupture.21
DISCUSSION
The increasing interest and clinical adaptation and the
use of endovascular prostheses to treat patients with AAAs
parallels the enthusiasm for patients reaping the benefits of
minimally invasive procedures. Increased use has been
encouraged by the relatively high success rates reported in
initial clinical trials.2,3,22 The initial challenges of fabricat-
ing devices that can be deployed precisely with endovas-
cular techniques have been overcome with the enthusiasm
for this procedure, leading many manufacturers to evalu-
ate new prototype devices. Although the success rates for
this new technology have paralleled increasing use during
the last 10 years since the initial clinical reports were
made, assessment of the long-term success and complica-
tions of the evolving devices rely on longitudinal studies of
success and complications. Several of the U.S. Food and
Drug Administration and international studies are accom-
plishing this goal, with manufacturers now being able to
use these data to make further product improvements for
future devices.
As with conventional aortobifemoral bypass in patients
with aneurysms, there are known complications that limit
the long-term success such as device thrombosis, infection,
ongoing atherosclerotic change, aneurysmal dilatation of
adjacent arterial segments, and a significant attrition in
patient populations caused by comorbid conditions.23,24
Although significant advances in reduction of periproce-
strated that syndromes that were thought to be associated
only with endoluminal grafts such as endoleaks have also
recently been reported to occur after conventional open
AAA repair.25 For these reasons it has become increasingly
apparent that a carefully designed analysis of our current
understanding of aneurysmal and atherosclerotic disease
and the implications of endoluminal graft deployment on
altering the course of these pathologic conditions is pro-
viding relevant new information that is significantly
enhancing our understanding of the utility and limitations
of these technologies.
In this study we have been able to compare the initial
aneurysm morphology after deployment of AneuRx bifur-
cated devices for AAA with serial contrast CT scan images,
with several important observations being made. As illus-
trated in several individual case studies, particularly related
to device failures, the three-dimensional CT reconstructions
not only displayed important information regarding the ini-
tial efficacy of the device as it was deployed but also showed
how device modifications could improve the function of the
prosthesis. An example of this is that the “stiff” proximal
portion of the body of an AneuRx device was altered to a
segmented design early in the clinical trial to better accom-
modate angulation in the proximal aortic neck. Although
this change was made on the basis of observations made
during initial cases with the AneuRx device, its implication
on long-term function has also been observed in recent
reports.21 As is apparent from the results in this analysis, the
three-dimensional CT and volume analyses have helped
monitor the patients after the procedure and to help decide
on the timing for additional interventions. Although it
appears that significant device movement is associated pri-
marily with the stiff body that has been replaced by the flex-
ible segmented prosthesis, further analysis of this
phenomenon is required, because only 22 patients in this
study had the flexible device, and follow-up beyond 1 year
is limited. It is also apparent that device realignment,
reflected by the increased renal-device distance, is accentu-
ated by aneurysm morphologic changes that occur as
aneurysms regress after exclusion. Based on the data from
these analyses, we now also increase the frequency of sur-
veillance in patients with rapid aneurysm regression.
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Fig 4. Sequential interactive angiograms over 3-year period in patient who had lumbar endoleak at 6 months after deployment that persisted
for 12 months and then underwent spontaneous thrombosis. During this interval patient’s aneurysm diameter and CSA decreased by 10 mm
and 49%. By 3 years, total volume had sequentially decreased by 28% and total thrombus volume by 40%. Note that as aneurysm regresses,
amount of thrombus in neck and iliac fixation sites decreases, and length of stent fixation becomes longer and more visible.
Fifty-one of 98 consecutively treated patients were
enrolled in this analysis, even though many more patients
have been monitored with several imaging examinations
during this interval. Although several patients have died of
unrelated illnesses and one has been lost to follow-up, the
remaining patient data were not analyzed because the CTs
were not available at all follow-up intervals, or the CTs
were acquired by techniques or in locations where the data
were not consistent with the entry criterion for this study.
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Fig 5. Sequential CT images over 3-year period demonstrating accommodation of 28-mm diameter AneuRx device to aneurysm that
decreased by 9 mm (28% cross-sectional), with corresponding decrease in aneurysm volume by 7% and thrombus volume by 27% over this
interval. Angle of proximal neck increased from 43° to 55°, with device diameter increasing from 25 mm after deployment to 28 mm at 3
years. Proximal neck diameter above device remained 31 mm diameter over time, whereas fixation site in neck dilated as length of proximal
device fixation increased. Note regression of left common iliac aneurysm over this interval.
Table III. Comparison of maximum diameter (mm) of aneurysms measured from axial CT images
acquired perpendicular to the patient, and images in a plane perpendicular to the centerline of the aorta in
patients with endoleaks and/or volume increases
Perpendicular to patient Perpendicular to centerline
Patient no. Before 1 year 2 years 3 years Before After 1 year 2 years 3 years
1 60 50 50 50 — 57.8 53.8 54.3 55.7
2 80 80 100 — — 78.3 83.1 113.9 —
3 60 55 — — 54.1 55.8 54.8 — —
4 58 58 58 58 59.3 58.5 60.4 59 —
5 50 48 48 — 48.3 49.1 47.6 46.3 —
6 58 48 48 — 49.9 46.2 — 39.2 —
7 68 65 65 70.1 70.1 70.2 68.6 69.7 —
8 65 68 70 — 58.8 59.8 61.6 78 —
9 40 40 43 — 39.2 39.5 39.8 41.5 —
10 50 50 — — — 51.7 52.9 — —
11 55 55 — — — 56.1 59.4 57.8 —
12 65 65 — — — 68.9 68.4 — —
13 60 66 — — — 57.8 66.2 — —
14 70 65 — — — 67.6 64.7 — —
15 50 48 — — 47.7 46 49.5 — —
—, Values not available.
Only patients with CTs performed by the outlined proto-
col with data available at each interval for interactive analy-
sis were used so that the correlation and accuracy of
imaging interpretations could be maximized. As part of
our clinical surveillance protocol, patients with endoleaks
or potential device-related problems such as angulation
with the stiff body devices had focused attempts at acquir-
ing CT images in compliance with the entry criterion for
this study, so that the results in this analysis are weighted
to an increased percentage of these patients. One addi-
tional bias that is apparent in these data is that our institu-
tion initiated the phase I trial with the AneuRx device and
had all of our patients in phase I and several in phase II
implanted with the “stiff body” device. For this reason
some of the phenomena associated with this prosthesis
such as migration, angulation, and increased incidence of
rupture after implantation are overemphasized in this
analysis because of the higher proportion of these patients
at our institution compared with the phase II results that
led to Food and Drug Administration approval of this
device.22 Although these factors affect the outcome of a
few patients in this analysis, they have no relevance to the
focus of this article, that is, the postimplant surveillance of
AAA endografts with interactive imaging.
As can be noted from this study, most patients had a
slow and progressive decrease in the diameter and volume
of their aneurysm during the 1 to 3 years of observation,
with limited adverse device reconfiguration being identi-
fied. The surveillance has required yearly CT scans, and
approximately 10% to 20% of the patients with persistent
endoleaks and evidence of device angulation have a more
frequent imaging protocol. In an even smaller group of
patients, interventions to place additional cuffs to manage
proximal distal or junctional endoleaks or to perform
catheter-based interventions to occlude lumbar or inferior
mesenteric artery endoleaks have occurred. In this study
aneurysm diameter and volume enlargement resulted in
one patient being converted to an open surgical repair and
others being observed or treated further by alternative
methods to prevent aneurysm progression.
Although the final algorithm for long-term surveil-
lance of patients after endoluminal graft deployment and
for determination of the appropriate time interval for rein-
tervention in cases where endograft deployment is unsuc-
cessful in preventing aneurysm enlargement is yet to be
determined, we have identified several situations where
the three-dimensional analysis and volume reconstruction
are of particular utility, enhancing surveillance for patients
who slowly have reduction in the diameter of the
aneurysm and do not have endoleaks. The focus of analy-
sis is to ensure that the device alignment in the aortic seg-
ment is not affected by morphologic changes so that there
is neither angulation nor shortening of the proximal or
distal fixation sites. As has been emphasized in the recent
analysis of aneurysm ruptures, it is also very important to
look at the overlap of modular components so that there
is not a change in the overlap zone or a tilt in the fixation
site so that secondary endoleaks can arise as a result of
malalignment of the device components.21 The recent rec-
ommendation for increasing the overlap in the contralat-
eral limb in the AneuRx bifurcated device to prevent
ruptures related to a leak from this juncture site after
aneurysm morphologic change exemplifies the importance
of the effect of morphology on device alignment. In two
patients we have deployed proximal aortic cuffs for a
severe angulation related to the proximal neck that devel-
oped as the aneurysm regressed. In both patients this
occurred in association with the early “stiff” proximal
body devices, with no cuffs being required for this defor-
mity during the last 2 years since the more flexible, proxi-
mal segmented device was introduced.
A more perplexing group of patients are those
whose aneurysm size does not change and in whom
there is no apparent endoleak or a small endoleak con-
fined to the lumbar arteries. The question of aneurysm
pressurization through the endoleak or pressurization of
the aneurysm by some other mechanism that is not
apparent on the CT images led us to begin to perform
the three-dimensional analysis and volume characteriza-
tion in these patients to ensure that there was not an iso-
lated aneurysmal volume increase even in light of no
change or small decreases in maximum aneurysm diam-
eter. Although this imaging protocol may be considered
anecdotal because it reflects one institution’s responses
to its own particular patient outcomes, we believe it is an
important component of our current surveillance mech-
anism and has enhanced our ability to make decisions
regarding intervention.
CONCLUSIONS
Significant variation in the quantitation of aneurysm
size occurs depending on the technique of CT assessment
used. In most patients diameter assessment is adequate,
particularly if diameters are measured on centerline CT
images. Volumetric analysis appears to be very helpful in
certain patients who do not show aneurysm regression, or
in whom the diameter increases or where endoleaks per-
sist. Three-dimensional reconstruction and volumetric
analysis are also useful to assess the mechanism by which
the endovascular device accommodates to morphology
changes and to determine criteria for reintervention.
The authors acknowledge the contribution made by
Peter Robbie, Medical Media Systems, Inc, who provided
the Preview Surgical Software analysis in this article.
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